In the Prevention of Malaria and HIV disease in Tororo pediatrics trial , HIV-infected Ugandan children randomized to receive lopinavir/ritonavir ( LPV/r ) - based antiretroviral therapy ( ART ) experienced a lower incidence of malaria compared with children receiving nonnucleoside reverse transcriptase inhibitor ( NNRTI ) - based ART .